Benzodiazepine Use During Hospitalization: Automated Identification of Potential Medication Errors and Systematic Assessment of Preventable Adverse Events

Abstract

ObjectiveBenzodiazepines and “Z-drug” GABA-receptor modulators (BDZ) are among the most frequently used drugs in hospitals. Adverse drug events (ADE) associated with BDZ can be the result of preventable medication errors (ME) related to dosing, drug interactions and comorbidities. The present study evaluated inpatient use of BDZ and related ME and ADE.MethodsWe conducted an observational study within a pharmacoepidemiological database derived from the clinical information system of a tertiary care hospital. We developed algorithms that identified dosing errors and interacting comedication for all administered BDZ. Associated ADE and risk factors were validated in medical records.ResultsAmong 53,081 patients contributing 495,813 patient-days BDZ were administered to 25,626 patients (48.3%) on 115,150 patient-days (23.2%). We identified 3,372 patient-days (2.9%) with comedication that inhibits BDZ metabolism, and 1,197 (1.0%) with lorazepam administration in severe renal impairment. After validation we classified 134, 56, 12, and 3 cases involving lorazepam, zolpidem, midazolam and triazolam, respectively, as clinically relevant ME. Among those there were 23 cases with associated adverse drug events, including severe CNS-depression, falls with subsequent injuries and severe dyspnea. Causality for BDZ was formally assessed as ‘possible’ or ‘probable’ in 20 of those cases. Four cases with ME and associated severe ADE required administration of the BDZ antagonist flumazenil.ConclusionsBDZ use was remarkably high in the studied setting, frequently involved potential ME related to dosing, co-medication and comorbidities, and rarely cases with associated ADE. We propose the implementation of automated ME screening and validation for the prevention of BDZ-related ADE.

Changes of consultation-liaison psychiatry practice in Italian general hospitals: A comparative 20-year multicenter study

“…With 10.3389/fpsyt.2022.959399 regards to mood stabilizers, the increase in prescription could reflect a change in their use for analgesic purposes as gradually emerged in medical literature (76)(77)(78). Overall, these findings mirror the aforementioned change in antidepressants prescription in the last decades, the increased prevalence of bipolar disorders and confirm the frequent use of benzodiazepines in medical settings both for sleep control as well as a means for rapid tranquillization (79). These data underline the need to further train non-specialists in psychiatry, within and outside the hospital, about the risks of benzodiazepines use in medically ill patients, especially in the elderly (80, 81), as well as the need to further develop CLP services with general practitioners to monitor pharmacotherapy (82).…”

Medicamentos potencialmente inapropriados (MPIS) para idosos: prevalência em um hospital terciário do Brasil

“…16 Os benzodiazepínicos são prescritos principalmente para o tratamento de insônia e ansiedade, podendo afetar a função cognitiva. Seu efeito sedativo é um fator de risco para quedas e fraturas 16,21,17 . O aumento no risco de quedas e fraturas entre idosos usuários de benzodiazepínicos tem sido atribuído a duas propriedades desses medicamentos: atividade sedativa e bloqueio α-adrenérgico.…”

<p>Single-use suvorexant for treating insomnia during overnight polysomnography in patients with suspected obstructive sleep apnea: a single-center experience</p>

“…In this study, no adverse event was observed in all the patients. A large observational study of 53,081 patients in an European country revealed that GABA A receptor hypnotic agents (eg, lorazepam and zolpidem) were administered to 48.3% of hospitalized patients 6. In consideration of the potential side effects of hypnotic agents, GABA A receptor hypnotic agents might 1) modify sleep architecture, 2) increase respiratory events during sleep (cause respiratory depression), 3) increase the risk of falls (or bone fracture), and 4) cause acute cognitive dysfunction and hallucination 15,16,27,29,30.…”

“…Benzodiazepines and/or non-benzodiazepines (ie, type A gamma-aminobutyric acid [GABA A ] receptor hypnotic agents) are most frequently used to treat insomnia worldwide, even during hospitalization 6. However, there are several concerns about the routine use of GABA A receptor agonists for patients with insomnia who might have undiagnosed OSA.…”